Plasma biomarkers for systemic inflammation in COVID-19 survivors.

Juan ZhaoMadison SchankLing WangXindi DangDechao CaoSushant KhanalLam N T NguyenYi ZhangXiao Y WuJames L AdkinsBenjamin J PeltonJinyu ZhangShunbin NingMohamed El GazzarJonathan P MoormanZhi Q Yao

Published in: Proteomics. Clinical applications (2022)

Our results indicate that several inflammatory proteins remain aberrantly dysregulated in COVID-19 survivors and CXCL10 might serve as a potential biomarker to typify COV-LH. Further characterization of these signature inflammatory molecules might improve the understanding of the long-term impacts of COVID-19 and provide new targets for the diagnosis and treatment of COVID-19 survivors with PASC.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
young adults
oxidative stress